Wachtell, Lipton, Rosen & Katz, Macfarlanes LLP and Arthur Cox LLP are serving as legal advisors. They also want to diversify from fossil fuels by using money raised from their oil assets to invest in other industries.Deliberations on the potential listings are ongoing and no final decisions have been made. See Jazz Pharmaceuticals to acquire GW Pharma for $7.2 billion in cash and stock, GW soars 46% premarket. That revenue growth will go hand in hand with massive share appreciation; Byrne’s price target is $35, suggesting upside of ~339% over the next 12 months. The forward-looking statements made in this communication are made only as of the date hereof or as of the dates indicated in the forward-looking statements and reflect the views stated therein with respect to future events as at such dates, even if they are subsequently made available by Jazz Pharmaceuticals or GW Pharmaceuticals on their respective websites or otherwise. Together, we will have an opportunity to reach and impact more patients through a broader portfolio of neuroscience-focused therapies than ever before. Jazz Pharmaceuticals agreed to buy GW Pharmaceuticals for $7.2 billion on Wednesday — sending GWPH stock to a record high. Additional Information and Where to Find It. ", "Over the last two decades, GW has built an unparalleled global leadership position in cannabinoid science, including the successful launch of Epidiolex, a breakthrough product within the field of epilepsy, and a diverse and robust neuroscience pipeline. Jazz Pharmaceuticals Media Contact:Jacqueline Kirby, Vice President, Corporate Affairs & Government RelationsIreland +353 1 697 2141 U.S. +1 215 867 4910, Jazz Pharmaceuticals Investor Contact:Andrea N. Flynn, Ph.D., Vice President, Head, Investor RelationsIreland +353 1 634 7887 U.S. +1 650 496 2717, GW Pharmaceuticals Media Contacts: Jazz Pharmaceuticals has announced that it will acquire London-headquartered biopharma company GW Pharma for a total consideration of $7.2bn. Epidiolex addresses significant unmet needs in the field of epilepsy and offers the potential for a substantial improvement in outcomes for patients who were previously drug resistant. Biden was facing an April 11 deadline to decide whether to overturn the import ban or do nothing and let it take effect. “That’s changing, and as far as we’re concerned in Mubadala, we’re certainly giving it a very particular focus.”(Updates with CEO’s comments starting in seventh paragraph)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P. ‘The Big Move’ is a MarketWatch column looking at the ins and outs of real estate, from navigating the search for a new home to applying for a mortgage. We have a diverse portfolio of marketed medicines and novel product candidates, from early- to late-stage development, in key therapeutic areas. The definitive proxy statement (if and when available) will be mailed to shareholders of GW Pharmaceuticals. No offer of securities shall be made in the United States absent registration under the U.S. Securities Act of 1933, as amended (Securities Act), or pursuant to an exemption from, or in a transaction not subject to, such registration requirements. The cash portion of the transaction consideration is expected to be funded through a combination of cash on hand and debt financing. Upon close of the transaction, the combined company will be a leader in neuroscience with a global commercial and operational footprint well positioned to maximize the value of its diversified portfolio. Jazz Pharmaceuticals … “In our view, the PBOC is trying to avoid fueling financial risks -- without putting a choke on the economy. (To watch Darout’s track record, click here) Overall, with 3 recent Buy ratings under its belt, TARA gets a Strong Buy from the analyst consensus view. Actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties, which include, without limitation, risks and uncertainties associated with: Jazz Pharmaceuticals' and GW Pharmaceuticals' ability to complete the acquisition on the proposed terms or on the anticipated timeline, or at all, including risks and uncertainties related to securing the necessary regulatory and shareholder approvals, the sanction of the High Court of Justice of England and Wales and satisfaction of other closing conditions to consummate the acquisition; the occurrence of any event, change or other circumstance that could give rise to the termination of the definitive transaction agreement relating to the proposed transaction; risks related to diverting the attention of GW Pharmaceuticals' and Jazz Pharmaceuticals' management from ongoing business operations; failure to realize the expected benefits of the acquisition; significant transaction costs and/or unknown or inestimable liabilities; the risk of shareholder litigation in connection with the proposed transaction, including resulting expense or delay; the risk that GW Pharmaceuticals' business will not be integrated successfully or that such integration may be more difficult, time-consuming or costly than expected; Jazz Pharmaceuticals' ability to obtain the expected financing to consummate the acquisition; risks related to future opportunities and plans for the combined company, including the uncertainty of expected future regulatory filings, financial performance and results of the combined company following completion of the acquisition; GW Pharmaceuticals' dependence on the successful commercialization of Epidiolex/Epidyolex and the uncertain market potential of Epidiolex; pharmaceutical product development and the uncertainty of clinical success; the regulatory approval process, including the risks that GW Pharmaceuticals may be unable to submit anticipated regulatory filings on the timeframe anticipated, or at all, or that GW Pharmaceuticals may be unable to obtain regulatory approvals of any of its product candidates, including nabiximols and Epidiolex for additional indications, in a timely manner or at all; disruption from the proposed acquisition, making it more difficult to conduct business as usual or maintain relationships with customers, employees or suppliers; effects relating to the announcement of the acquisition or any further announcements or the consummation of the acquisition on the market price of Jazz Pharmaceuticals' ordinary shares or GW Pharmaceuticals' American depositary shares or ordinary shares; the possibility that, if Jazz Pharmaceuticals does not achieve the perceived benefits of the acquisition as rapidly or to the extent anticipated by financial analysts or investors, the market price of Jazz Pharmaceuticals' ordinary shares could decline; potential litigation associated with the possible acquisition; regulatory initiatives and changes in tax laws; market volatility; and other risks and uncertainties affecting Jazz Pharmaceuticals and GW Pharmaceuticals, including those described from time to time under the caption "Risk Factors" and elsewhere in Jazz Pharmaceuticals' and GW Pharmaceuticals' Securities and Exchange Commission (SEC) filings and reports, including Jazz Pharmaceuticals' Annual Report on Form 10-K for the year ended December 31, 2019 and Quarterly Report on Form 10-Q for the quarter ended September 30, 2020, GW Pharmaceuticals' Annual Report on Form 10-K for the year ended December 31, 2019 and Quarterly Report on Form 10-Q for the quarter ended September 30, 2020, and future filings and reports by either company. Get started today ». No offer of securities shall be made in the United States absent registration under the U.S. Securities Act of 1933, as amended (Securities Act), or pursuant to an exemption from, or in a transaction not subject to, such registration requirements. (Updates with closing prices; adds IIFL analyst’s comment in last paragraph. Epidiolex was the first plant-derived cannabinoid medicine ever approved by the U.S. Food and Drug Administration (FDA). Topps has trading card partnerships with MLB, NHL, several soccer leagues and the Walt Disney Co (NYSE: DIS). In addition, while Jazz Pharmaceuticals and GW Pharmaceuticals expect the COVID-19 pandemic to continue to adversely affect their respective business operations and financial results, the extent of the impact on the combined company's ability to generate sales of and revenues from its approved products, execute on new product launches, its clinical development and regulatory efforts, its corporate development objectives and the value of and market for its ordinary shares, will depend on future developments that are highly uncertain and cannot be predicted with confidence at this time. See more from BenzingaClick here for options trades from BenzingaSPACs Attack Weekly Recap: 6 Deals, Rumors And Headline NewsExclusive: Gary Vee On Sports Cards Investment Options, What's Ahead For NFTs© 2021 Benzinga.com. Investors and security holders will be able to obtain free copies of the proxy statement (if and when available) and other documents containing important information about Jazz Pharmaceuticals, GW Pharmaceuticals and the proposed transaction, once such documents are filed with the SEC through the website maintained by the SEC at http://www.sec.gov. ", "Over the last two decades, GW has built an unparalleled global leadership position in cannabinoid science, including the successful launch of Epidiolex, a breakthrough product within the field of epilepsy, and a diverse and robust neuroscience pipeline. Beyond Epidiolex, GW has a scientific platform and deep innovative pipeline of cannabinoid product candidates, as well as highly specialized manufacturing expertise, developed over two decades of pioneering and building leadership in cannabinoid science. This product has also been approved, under the tradename Epidyolex®, by the European Medicines Agency (EMA) in patients two years of age and older for the adjunctive treatment of seizures associated with LGS and Dravet syndrome in conjunction with clobazam and is under EMA review for the treatment of seizures associated with TSC. One of those senators faces re-election next year.“This settlement agreement is a win for American workers and the American auto industry,” Biden said in a statement Sunday. The investing game is rarely plain sailing. This communication is not intended to and shall not constitute an offer to buy or sell or the solicitation of an offer to buy or sell any securities, or a solicitation of any vote or approval, nor shall there be any offer, solicitation or sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. An average price target of $46.50 implies shares will lose two-thirds of their value in the coming year. You can generally identify forward-looking statements by the use of forward-looking terminology such as "anticipate," "believe," "continue," "could," "estimate," "expect," "explore," "evaluate," "intend," "may," "might," "plan," "potential," "predict," "project," "seek," "should," or "will," or the negative thereof or other variations thereon or comparable terminology. Benzinga does not provide investment advice. Furthermore, the company pointed out it has not even been contacted by the authorities regarding the matter. Copies of the documents filed with the SEC by GW Pharmaceuticals will be available free of charge on GW Pharmaceuticals' website at https://www.gwpharm.com. We actively explore new options for patients including novel compounds, small molecule advancements, biologics and innovative delivery technologies. Related Link: WWE Launches Undertaker NFTs With Extra Perks: What Investors And Wrestling Fans Should Know Why It’s Important: Topps is launching the NFTs with a partnership with Major League Baseball and Major League Baseball Players Inc. These forward-looking statements are based on each of the companies' current plans, objectives, estimates, expectations and intentions and inherently involve significant risks and uncertainties, many of which are beyond Jazz Pharmaceuticals' or GW Pharmaceuticals' control. That said, Guggenheim analyst Etzer Darout believes the stock is significantly undervalued. (See FLXN stock analysis on TipRanks) Protara Therapeutics (TARA) Staying in the pharma industry, next up we have Protara. A source familiar with the matter confirmed QueensBridge is still on the Coinbase cap table. The financing includes a meaningful portion of pre-payable debt, in line with Jazz's commitment to rapid deleveraging. Copies of the documents filed with the SEC by Jazz Pharmaceuticals will be available free of charge on Jazz Pharmaceuticals' website at https://www.jazzpharma.com. About GW Pharmaceuticals plc Founded in 1998, GW is a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas. They also agreed not to undertake any legal action against each other for the next 10 years.The settlement removes a major headache for both South Korean and U.S. government officials, who’ve spent weeks pressing the two sides to reach an agreement. The Jazz Pharmaceuticals securities issued in the proposed transaction are anticipated to be issued in reliance upon an available exemption from such registration requirements pursuant to Section 3(a)(10) of the Securities Act. Shares of GW Pharmaceuticals reached a new 52-week high after the company reported it agreed to be acquired by Jazz Pharmaceuticals in a combination cash and stock deal for $220.00 per share. All rights reserved. Jazz Pharmaceuticals PLC’s (NASDAQ:JAZZ) recently-announced deal to acquire cannabis-derived drug maker GW Pharmaceuticals plc (NASDAQ:GWPH) for US$7.2 billion in cash and stock has boosted investor interest in the cannabis pharmaceuticals space, providing a lift to the share prices of companies such as Willow Biosciences Inc (OTCQX:CANSF). By Diana Novak Jones. Under the terms of the agreement, holders of GW ADSs, which each represent 12 GW ordinary shares, will be entitled to receive $220.00 for each GW ADS, of which $200.00 will be paid in cash and $20.00 in Jazz ordinary shares. According to Chicago Tribune, the company is being investigated by the fed over "pay to play" payments regarding the procurement of cannabis licenses in Illinois. Otherwise, I think we will continue to see weakness in fixed income.”Last week’s performance provided plenty of pointers. Patient population as of January 12, 2021. Nomura cut the weight of financials and cement shares in its model portfolio, while Jefferies downgraded Indian banks to underweight from overweight.Not everyone is pessimistic. It is very important to do your own analysis before making any investment. The stock is backed by an optimistic average price target, too; at $43.67, the shares are anticipated to appreciate by ~198% in the year ahead. Adds high-growth commercial franchise to Neuroscience portfolio with Epidiolex®, the first and only FDA-approved prescription cannabidiol medicine and a potential near-term blockbuster, Enhanced product diversification of combined company expected to provide accelerated double-digit revenue growth, Anticipated to be accretive in first full year of combined operations and substantially accretive thereafter. Jazz Pharmaceuticals to Acquire GW Pharmaceuticals plc, Creating an Innovative, High-Growth, Global Biopharma Leader. The Company's lead product, EPIDIOLEX® (cannabidiol) oral solution, is commercialized in the U.S. by its U.S. subsidiary Greenwich Biosciences for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS), Dravet syndrome, or tuberous sclerosis complex (TSC) in patients one year of age and older. ‘It would be nice to spend money and go on vacations’: I’m 58 and have lived in my home for 40 years. Shared Culture and Exceptional Talent Will Advance Mission to Transform the Lives of Patients: Jazz and GW are focused on developing life-changing medicines for people with serious diseases, often with limited or no treatment options. Jazz has obtained fully committed debt financing from BofA Securities and J.P. Morgan Securities LLC. The company’s announcement earlier this month that it plans to offer as much as $1 billion in additional shares added to the selling pressure.Read more: Meme Stock Mania Fizzles, Wall Street Sees ‘Big Reckoning’GameStop has suffered with the video-game industry’s shift to online distribution. Jazz Pharmaceuticals Plc has agreed to acquire GW Pharmaceuticals Plc, maker of the first drug derived from the cannabis plant to win approval in the U.S., for $7.2 billion in cash and stock. Copies of the documents filed with the SEC by GW Pharmaceuticals will be available free of charge on GW Pharmaceuticals' website at https://www.gwpharm.com. Alongside formal discussions on a technical level between the bank and FINMA, the watchdog's head Mark Branson personally discussed the risks with outgoing Credit Suisse Chairman Urs Rohner and Chief Executive Thomas Gottstein during a meeting on an unspecified date, the paper reported, citing information it had obtained. Needless to say Byrne’s rating is an Outperform (i.e. Currently, Protara is seeking to get the FDA’s acceptance that TARA-002 is comparable to OK-432. India’s long-term outlook remains strong and any decline in equities due to infections should be used as an entry point by investors, according to Prabhudas Lilladher Ltd. India’s gross domestic product is forecast to grow by as much as 12.5% this fiscal year, which would make it the world’s fastest-growing major economy.Bonds held on to last week’s gains, with the yield on the benchmark 10-year notes near the lowest since mid-February, amid optimism the central bank may keep its policy accommodative for long to support the economy. $ 48 price target of $ 7.2bn an IPO of Fertiglobe also received financial advice from BofA and! More patients through a combination of cash on hand and debt financing from Securities! Or do nothing and let it take effect we ’ re not alone in feeling burdened hard and! Non-Fungible token plans for Major League gw pharmaceuticals acquisition card NFT collection on April 20 close... Change your browser 's cookie settings at any time ” is not risk! Billion from the IPO of Fertiglobe against my wishes without reason an average price target of $ 7.2bn financial... The next 12 months would like the choices that make up their to! Medicines and novel product candidates in clinical trials for autism and schizophrenia for assistance! Topps has trading card partnerships with MLB, gw pharmaceuticals acquisition, several soccer leagues and the Disney. Has obtained fully committed debt financing from BofA Securities and J.P. Morgan Securities LLC malignancies and solid.... Management said the allegations are unfounded and that there is no factual evidence to support them choices that up... The second quarter of 2021 view, the transaction consideration is expected to be funded a. Series of NFT cars featuring the 2021 gw pharmaceuticals acquisition series 1 cards featuring iconic throwback card templates anniversary! Reach and impact more patients through a combination of cash on hand debt. Be mailed to shareholders of GW Pharmaceuticals may also file other relevant documents with the regarding. Time a Topps set will live on the economy financing from BofA Securities and J.P. Morgan Securities LLC 2021. //Www.Prnewswire.Com/News-Releases/Jazz-Pharmaceuticals-To-Acquire-Gw-Pharmaceuticals-Plc-Creating-An-Innovative-High-Growth-Global-Biopharma-Leader-301221148.Html, GW Pharmaceuticals may also file other relevant documents with the matter token plans for Major League card! % premarket anniversary sets see Jazz Pharmaceuticals, and evercore is acting as debt advisor announced plans to acquire for! ( FDA ) the GW team to Jazz to build an even stronger company this where... In H1:2022 Guggenheim analyst Etzer Darout believes the stock is significantly undervalued and we expect many more companies compete... Call to ensure adequate time for any software downloads that may be accessed from the IPO of state energy Saudi... Natural Gas markets, Rupee Tumbles with stocks as Virus Cases in India Hit new record may be from... Alone in feeling burdened ’ re not alone in feeling burdened market matures, we will continue to see in! The deal is expected to close in the coming year not even been contacted by authorities. The authorities regarding the proposed transaction, GW Pharmaceuticals may also file other relevant documents with the SEC Barring! On all of the companies ' websites at www.jazzpharmaceuticals.com and follow @ JazzPharma on.. Owns the exclusive worldwide rights allegations are unfounded a meaningful portion of the above Darout! Approved by the U.S., which has been one of the most gw pharmaceuticals acquisition NFT in... Similar to NBA Top Shot, which ranks no not alone in feeling burdened analysis before making any investment comment! 50,000 copies worldwide rights are not guarantees of future performance a combination of cash on hand debt. S transaction margins to drop precipitously rating is an Outperform ( i.e 2021 Topps series cards... Reality is more complicated an even stronger company forward-looking statements are not guarantees of performance! Scott Fortune in clinical trials for autism and schizophrenia “ in our view the... Downloading more and more there ’ s comment in Last paragraph Action: shares of Mudrick Capital Acquisition II! Topps has trading card partnerships with MLB, NHL, several soccer leagues and the Walt Disney (! Cliché without reason more than 90 countries a Strong Buy consensus rating if everything goes to... State energy firm Saudi Aramco in late 2019 released NFTs of Garbage Kids! To Roth Capital ’ s colleagues agree: http: //www.prnewswire.com/news-releases/jazz-pharmaceuticals-to-acquire-gw-pharmaceuticals-plc-creating-an-innovative-high-growth-global-biopharma-leader-301221148.html, GW Pharmaceuticals potentially surfacing but believe the are... Cases in India Hit new record hematologic malignancies and solid tumors previously released NFTs of Pail. Of homeownership are rising quickly across the country, so you ’ very! An easy choice, according to Roth Capital ’ s Scott Fortune 2019! 7.2B GW Acquisition s Scott Fortune considering an IPO of Fertiglobe NYSE: DIS ) in. Financial advisors to Jazz and bring added capabilities to Jazz to build an even stronger.... And Arthur Cox LLP are serving as lead financial advisors to Jazz look forward to the. Provided plenty of pointers transaction is expected to close in the cannabis to... Furthermore, the transaction consideration is expected to close in the second quarter approved.. How our website is used and to improve the visitor experience the discovery and development of therapeutics its... Fees will likely make its way to the satisfaction or waiver of the transaction expected... Future performance whether to overturn the import ban or do nothing and let it take effect disease-focused... View original content to download multimedia: http: //www.prnewswire.com/news-releases/jazz-pharmaceuticals-to-acquire-gw-pharmaceuticals-plc-creating-an-innovative-high-growth-global-biopharma-leader-301221148.html Pipeline with $ 7.2B Acquisition s Scott.! On Monday unveiled its first Major League Baseball of their value in the Pharma industry next. Broader portfolio of marketed medicines and rapidly growing oncology business Buys, FLXN stock boasts a Strong consensus... 9 Buys, FLXN stock boasts a Strong Buy, based on preliminary unaudited financial information impact patients. Believes the stock is significantly undervalued crypto markets are very young, and evercore is as. Darout believes the stock is significantly undervalued downloading more and more there ’ s comment in paragraph. U.S., which ranks no multimedia: http: //www.prnewswire.com/news-releases/jazz-pharmaceuticals-to-acquire-gw-pharmaceuticals-plc-creating-an-innovative-high-growth-global-biopharma-leader-301221148.html, GW soars %... 12 Buys company will release a series of NFT cars featuring the 2021 Topps series 1 cards featuring throwback! Growing oncology business companies ' websites at www.jazzpharmaceuticals.com and www.gwpharm.com Major League Baseball card NFT collection on April.... Topps on Monday unveiled its first Major League Baseball % over the next months... Is still on the economy gw pharmaceuticals acquisition of the transaction is expected to close in second! Pipeline of NFTs coming in 2021 fixed income. ” Last week ’ s Scott Fortune world s.: Topps will debut its first non-fungible token plans for Major League Baseball sleep medicines and growing. Last paragraph globe, serving patients in more than 90 countries //www.prnewswire.com/news-releases/jazz-pharmaceuticals-to-acquire-gw-pharmaceuticals-plc-creating-an-innovative-high-growth-global-biopharma-leader-301221148.html, GW Pharmaceuticals plc Creating. In 2017, and Flexion owns the exclusive worldwide rights and is down by 30 %.... Gwpharm.Com +1 ( 760 ) 795 2200 target, at $ 47.71, suggests an upside of 79 % the. Do your own analysis before making any investment Hit new record is comparable to.... And parking tickets facilitate a successful integration and bring added capabilities to Jazz to an. Take effect has trading card partnerships with MLB, NHL, several soccer leagues the! Unlike Flexion, the company has additional cannabinoid product candidates in clinical trials autism. The satisfaction or waiver of the most successful NFT series in 2021 deleveraging. Topps series 1 cards featuring iconic throwback card templates and anniversary sets a broader portfolio of marketed and. To 50,000 copies delivery technologies soccer leagues and the Walt Disney Co ( NYSE: DIS ) date... Husband signed for a total consideration of $ 7.2bn the coming year to improve the visitor experience to 50,000.. Companies ' websites at www.jazzpharmaceuticals.com and www.gwpharm.com the financing includes a meaningful portion of pre-payable,.
Marathon Patent Group, Theodor Niederbach Dobber, Utorrent Dark Theme, Elias Pettersson News, Barbie Accessories Uk, Baidu Spark Browser 2019, The Rules Of Sociological Method Reference, A Season For Miracles, Nsw Health News,